For the quarter ending 2025-09-30, NAUT has $200,915K in assets. $31,776K in debts. $23,875K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 23,875 | 34,457 | ||
| Short-term investments | 107,552 | 113,416 | ||
| Prepaid expenses and other current assets | 2,898 | 2,852 | ||
| Total current assets | 134,325 | 150,725 | ||
| Property and equipment, net | 3,624 | 3,728 | ||
| Operating lease right-of-use assets | 24,727 | 25,920 | ||
| Long-term investments | 37,059 | 31,636 | ||
| Other long-term assets | 1,180 | 1,180 | ||
| Total assets | 200,915 | 213,189 | ||
| Accounts payable | 893 | 974 | ||
| Accrued expenses and other liabilities | 3,880 | 2,938 | ||
| Current portion of operating lease liabilities | 4,209 | 4,225 | ||
| Total current liabilities | 8,982 | 8,137 | ||
| Operating lease liabilities, net of current portion | 22,794 | 23,958 | ||
| Total liabilities | 31,776 | 32,095 | ||
| Common stock, 0.0001 par value, 1,000,000,000 shares authorized as of september30, 2025 and december31, 2024 126,305,122 and 126,106,176 shares issued and outstanding as of september30, 2025 and december31, 2024, respectively | 13 | 13 | ||
| Additional paid-in capital | 487,165 | 485,669 | ||
| Accumulated other comprehensive income | 200 | 77 | ||
| Accumulated deficit | -318,239 | -304,665 | ||
| Total stockholders equity | 169,139 | 181,094 | ||
| Total liabilities and stockholders' equity | 200,915 | 213,189 | ||
Nautilus Biotechnology, Inc. (NAUT)
Nautilus Biotechnology, Inc. (NAUT)